230 related articles for article (PubMed ID: 24043897)
1. Cholera toxin directly enhances IL-17A production from human CD4+ T cells.
Tsai HC; Wu R
J Immunol; 2013 Oct; 191(8):4095-102. PubMed ID: 24043897
[TBL] [Abstract][Full Text] [Related]
2. Cholera toxin enhances interleukin-17A production in both CD4
Tsai HC; Velichko S; Lee S; Wu R
Immunology; 2018 Jul; 154(3):500-509. PubMed ID: 29377102
[TBL] [Abstract][Full Text] [Related]
3. CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues.
Zhang W; Nie L; Wang Y; Wang XP; Zhao H; Dongol S; Maharjan S; Cheng L
PLoS One; 2013; 8(6):e66286. PubMed ID: 23823618
[TBL] [Abstract][Full Text] [Related]
4. Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1 signaling.
Larena M; Holmgren J; Lebens M; Terrinoni M; Lundgren A
J Immunol; 2015 Apr; 194(8):3829-39. PubMed ID: 25786687
[TBL] [Abstract][Full Text] [Related]
5. Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase/prostaglandin E2 pathway, independent of IL-23.
Paulissen SM; van Hamburg JP; Davelaar N; Asmawidjaja PS; Hazes JM; Lubberts E
J Immunol; 2013 Aug; 191(3):1364-72. PubMed ID: 23817417
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells.
Hirata T; Osuga Y; Takamura M; Kodama A; Hirota Y; Koga K; Yoshino O; Harada M; Takemura Y; Yano T; Taketani Y
Endocrinology; 2010 Nov; 151(11):5468-76. PubMed ID: 20881253
[TBL] [Abstract][Full Text] [Related]
7. Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease.
Perreau M; Rozot V; Welles HC; Belluti-Enders F; Vigano S; Maillard M; Dorta G; Mazza-Stalder J; Bart PA; Roger T; Calandra T; Nicod L; Harari A
Eur J Immunol; 2013 Apr; 43(4):939-48. PubMed ID: 23436562
[TBL] [Abstract][Full Text] [Related]
8. Upregulated IL-17A secretion and CCR6 co-expression in Treg subsets are related to the imbalance of Treg/Th17 cells in active UC patients.
Long Y; Zhao X; Xia C; Li X; Fan C; Liu C; Wang C
Scand J Immunol; 2020 Jun; 91(6):e12842. PubMed ID: 31660620
[TBL] [Abstract][Full Text] [Related]
9. Circulating Th17, Th22, and Th1 cells are increased in psoriasis.
Kagami S; Rizzo HL; Lee JJ; Koguchi Y; Blauvelt A
J Invest Dermatol; 2010 May; 130(5):1373-83. PubMed ID: 20032993
[TBL] [Abstract][Full Text] [Related]
10. Regulation of IL-17A production is distinct from IL-17F in a primary human cell co-culture model of T cell-mediated B cell activation.
Melton AC; Melrose J; Alajoki L; Privat S; Cho H; Brown N; Plavec AM; Nguyen D; Johnston ED; Yang J; Polokoff MA; Plavec I; Berg EL; O'Mahony A
PLoS One; 2013; 8(3):e58966. PubMed ID: 23505568
[TBL] [Abstract][Full Text] [Related]
11. A distinct regulatory role of Th17 cytokines IL-17A and IL-17F in chemokine secretion from lung microvascular endothelial cells.
Fujie H; Niu K; Ohba M; Tomioka Y; Kitazawa H; Nagashima K; Ohrui T; Numasaki M
Inflammation; 2012 Jun; 35(3):1119-31. PubMed ID: 22219048
[TBL] [Abstract][Full Text] [Related]
12. TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation.
van Hamburg JP; Asmawidjaja PS; Davelaar N; Mus AM; Cornelissen F; van Leeuwen JP; Hazes JM; Dolhain RJ; Bakx PA; Colin EM; Lubberts E
Ann Rheum Dis; 2012 Apr; 71(4):606-12. PubMed ID: 22219138
[TBL] [Abstract][Full Text] [Related]
13. The role of IL-15 in activating STAT5 and fine-tuning IL-17A production in CD4 T lymphocytes.
Pandiyan P; Yang XP; Saravanamuthu SS; Zheng L; Ishihara S; O'Shea JJ; Lenardo MJ
J Immunol; 2012 Nov; 189(9):4237-46. PubMed ID: 22993203
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of USF2 in refractory rheumatoid arthritis and its regulation of proinflammatory cytokines in Th17 cells.
Hu D; Tjon EC; Andersson KM; Molica GM; Pham MC; Healy B; Murugaiyan G; Pochet N; Kuchroo VK; Bokarewa MI; Weiner HL
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30639-30648. PubMed ID: 33203678
[TBL] [Abstract][Full Text] [Related]
15. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
[TBL] [Abstract][Full Text] [Related]
16. Expansion, isolation and first characterization of bovine Th17 lymphocytes.
Cunha P; Vern YL; Gitton C; Germon P; Foucras G; Rainard P
Sci Rep; 2019 Nov; 9(1):16115. PubMed ID: 31695097
[TBL] [Abstract][Full Text] [Related]
17. The IL17A and IL17F loci have divergent histone modifications and are differentially regulated by prostaglandin E2 in Th17 cells.
Adamik J; Henkel M; Ray A; Auron PE; Duerr R; Barrie A
Cytokine; 2013 Oct; 64(1):404-12. PubMed ID: 23800789
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosis.
Truchetet ME; Allanore Y; Montanari E; Chizzolini C; Brembilla NC
Ann Rheum Dis; 2012 Dec; 71(12):2044-50. PubMed ID: 22814427
[TBL] [Abstract][Full Text] [Related]
19. Unlike αβ T cells, γδ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22.
Raifer H; Mahiny AJ; Bollig N; Petermann F; Hellhund A; Kellner K; Guralnik A; Reinhard K; Bothur E; Huber M; Bauer S; Löhning M; Kiss EA; Ganal SC; Diefenbach A; Korn T; Lohoff M
Eur J Immunol; 2012 Dec; 42(12):3189-201. PubMed ID: 22961652
[TBL] [Abstract][Full Text] [Related]
20. The roles of IFN-γ versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts.
Kato H; Endres J; Fox DA
Mod Rheumatol; 2013 Nov; 23(6):1140-50. PubMed ID: 23306426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
